Ahmed Yousaf1, Rahul Raiker1, Stephen M Davis2,3, Swapna Gayam4, Zachary Zinn5. 1. Department of Dermatology, West Virginia University, 64 Medical Center Drive, PO Box 9100, 26506, Morgantown, WV, USA. 2. Department of Health Policy, Management & Leadership, West Virginia University, Morgantown, WV, USA. 3. Department of Emergency Medicine, West Virginia University, Morgantown, WV, USA. 4. Department of Medicine, Section of Gastroenterology and Hepatology, West Virginia University, Morgantown, WV, USA. 5. Department of Dermatology, West Virginia University, 64 Medical Center Drive, PO Box 9100, 26506, Morgantown, WV, USA. zzinn@hsc.wvu.edu.
Abstract
BACKGROUND: Psoriasis is associated with cardiovascular disease, inflammatory bowel disease (IBD), metabolic syndrome, and psychiatric disease. Furthermore, psoriasis is associated with immune dysregulation and systemic inflammation. OBJECTIVE: To determine the association of psoriasis and psoriatic arthritis with IBD and the association of the combination of psoriasis or psoriatic arthritis with IBD and other gastrointestinal illnesses. METHODS: Discharge data from the 2000-2014 Nationwide Inpatient Sample, Healthcare Cost and Utilization Project (HCUP), which approximates a 20% stratified sample of all US hospitalizations, were analyzed. Multivariable logistic regression was used to examine the association between psoriasis and psoriatic arthritis with IBD and 23 gastrointestinal illnesses adjusting for sociodemographic characteristics. RESULTS: Psoriasis was associated with IBD (Crohn's disease adjusted odds ratio (aOR) = 2.13, 95% confidence interval (CI) [2.0-2.3], p < 0.001). When adjusting for sociodemographics and IBD, psoriasis was associated with 21 of 23 gastrointestinal diseases examined, most notably celiac disease, autoimmune hepatitis, and non-alcoholic fatty liver disease. Psoriatic arthritis was also associated with IBD (Crohn's disease, aOR = 1.95, 95% CI [1.7-2.2], and ulcerative colitis, aOR = 2.66, 95% CI [2.4-2.9]). CONCLUSION: Psoriasis and psoriatic arthritis inpatients have an associated increase in IBD and numerous other gastrointestinal illnesses.
BACKGROUND: Psoriasis is associated with cardiovascular disease, inflammatory bowel disease (IBD), metabolic syndrome, and psychiatric disease. Furthermore, psoriasis is associated with immune dysregulation and systemic inflammation. OBJECTIVE: To determine the association of psoriasis and psoriatic arthritis with IBD and the association of the combination of psoriasis or psoriatic arthritis with IBD and other gastrointestinal illnesses. METHODS: Discharge data from the 2000-2014 Nationwide Inpatient Sample, Healthcare Cost and Utilization Project (HCUP), which approximates a 20% stratified sample of all US hospitalizations, were analyzed. Multivariable logistic regression was used to examine the association between psoriasis and psoriatic arthritis with IBD and 23 gastrointestinal illnesses adjusting for sociodemographic characteristics. RESULTS: Psoriasis was associated with IBD (Crohn's disease adjusted odds ratio (aOR) = 2.13, 95% confidence interval (CI) [2.0-2.3], p < 0.001). When adjusting for sociodemographics and IBD, psoriasis was associated with 21 of 23 gastrointestinal diseases examined, most notably celiac disease, autoimmune hepatitis, and non-alcoholic fatty liver disease. Psoriatic arthritis was also associated with IBD (Crohn's disease, aOR = 1.95, 95% CI [1.7-2.2], and ulcerative colitis, aOR = 2.66, 95% CI [2.4-2.9]). CONCLUSION: Psoriasis and psoriatic arthritis inpatients have an associated increase in IBD and numerous other gastrointestinal illnesses.
Authors: Stephan R Vavricka; Lionel Brun; Pierluigi Ballabeni; Valérie Pittet; Bettina Mareike Prinz Vavricka; Jonas Zeitz; Gerhard Rogler; Alain M Schoepfer Journal: Am J Gastroenterol Date: 2010-08-31 Impact factor: 10.864
Authors: Luca Miele; Selenia Vallone; Consuelo Cefalo; Giuseppe La Torre; Carmine Di Stasi; Fabio M Vecchio; Magda D'Agostino; Maria L Gabrieli; Vittoria Vero; Marco Biolato; Maurizio Pompili; Giovanni Gasbarrini; Gianludovico Rapaccini; Pierluigi Amerio; Clara De Simone; Antonio Grieco Journal: J Hepatol Date: 2009-06-26 Impact factor: 25.083
Authors: Hester Eppinga; Christa J Sperna Weiland; H Bing Thio; C Janneke van der Woude; Tamar E C Nijsten; Maikel P Peppelenbosch; Sergey R Konstantinov Journal: J Crohns Colitis Date: 2016-03-12 Impact factor: 9.071
Authors: Francesca Capon; Paola Di Meglio; Joanna Szaub; Natalie J Prescott; Christina Dunster; Laura Baumber; Kirsten Timms; Alexander Gutin; Victor Abkevic; A David Burden; Jerry Lanchbury; Jonathan N Barker; Richard C Trembath; Frank O Nestle Journal: Hum Genet Date: 2007-06-22 Impact factor: 4.132
Authors: Maryam M Asgari; Jashin J Wu; Joel M Gelfand; Craig Salman; Jeffrey R Curtis; Leslie R Harrold; Lisa J Herrinton Journal: Pharmacoepidemiol Drug Saf Date: 2013-05-02 Impact factor: 2.890